Roman Nation, MD
Family Medicine · Panama City, FLNPI 1710070438
Payments from drug & device makers
Across 355 payments — averaging $165.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dendreon Pharmaceuticals LLC$48K
- CGG Medical Inc$6K
- AbbVie$788
- Pfizer$546
- Novo Nordisk$527
- AstraZeneca$337
- plus $3K from 29 others
What the payments were for
- Consulting fees$48,00082%
- Speaking & faculty fees$6,00010%
- Food & beverage$4,7068%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 8 | $48,000 |
| CGG Medical Inc | 48 | $6,000 |
| AbbVie(2 entities) | 49 | $788 |
| Pfizer | 32 | $546 |
| Novo Nordisk | 44 | $527 |
| AstraZeneca | 23 | $337 |
| Lilly USA, LLC | 22 | $311 |
| Amgen | 20 | $309 |
| Dexcom, Inc. | 9 | $193 |
| Amarin Pharma, Inc. | 10 | $190 |
| Merck | 13 | $185 |
| Mylan Specialty L.p. | 9 | $168 |
| Grifols USA, LLC | 8 | $158 |
| Boehringer Ingelheim | 6 | $127 |
| Novartis | 7 | $116 |
| Sanofi-aventis U.S. LLC | 5 | $86 |
| Eisai Inc. | 5 | $83 |
| Jazz Pharmaceuticals Inc. | 3 | $66 |
| GSK | 4 | $53 |
| Kowa Pharmaceuticals America, Inc. | 4 | $52 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $49 |
| Exact Sciences | 3 | $48 |
| Bayer | 3 | $48 |
| Corcept Therapeutics | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| Johnson & Johnson | 2 | $27 |
| Teva Pharmaceuticals USA, Inc. | 2 | $24 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Abbott | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Shire North American Group Inc | 1 | $15 |
| Medtronic | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROVENGE$48,000
How this compares
$58,720 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 31 | $48,169 |
| EliquisApixaban | 52 | $43,143 |
| JardianceEmpagliflozin | 19 | $18,293 |
| EntrestoSacubitril/Valsartan | 12 | $8,949 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 256 | $5,275 |
| Testosterone Cypionate | 27 | $2,328 |
| Liothyronine Sodium | 46 | $2,175 |
| Morphine Sulfate ErMorphine Sulfate | 43 | $1,679 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 44 | $1,211 |
| Levothyroxine Sodium | 123 | $1,147 |
| Atorvastatin Calcium | 123 | $1,131 |
| Omega-3 Acid Ethyl Esters | 21 | $1,091 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $988 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 29 | $986 |
| Omeprazole | 80 | $920 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $527 | $48,16931 claims |
| PfizerEliquis | $546 | $43,14352 claims |
| Boehringer IngelheimJardiance | $127 | $18,29319 claims |
| NovartisEntresto | $116 | $8,94912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Panama City
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
- Dario AltamiranoHialeah$15.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.